BG
NUVB icon

Baupost Group’s Nuvation Bio NUVB Stock Holding History

Baupost Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,808,194
Closed -$9.23M – 34
2022
Q4 		$9.23M Sell
4,808,194
-5,610,000
-54% -$11.4M 0.15% 29
2022
Q3 		$23.3M Hold
10,418,194
– – 0.4% 29
2022
Q2 		$33.8M Sell
10,418,194
-25,300
-0.2% -$110K 0.5% 28
2022
Q1 		$54.9M Buy
10,443,494
+1,820,473
+21% +$10.2M 0.59% 25
2021
Q4 		$73M Hold
8,623,021
– – 0.72% 25
2021
Q3 		$85.4M Hold
8,623,021
– – 0.78% 27
2021
Q2 		$77.1M Hold
8,623,021
– – 0.63% 27
2021
Q1 		$82.4M Buy
+8,623,021
New +$96.4M 0.66% 29

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Baupost Group's NUVB Position: Q1 2023 in Review

Baupost Group sold out of Nuvation Bio (NUVB) in Q1 2023, closing a stake of 4,808,194 shares — an estimated $9.23M sold.

Baupost Group first reported a position in NUVB in Q1 2021 and held it in 8 quarters. The position peaked at $85.4M in Q3 2021. 129 funds tracked by Wall St. Rank hold NUVB as of Q1 2023.

  • Baupost Group reported no remaining Nuvation Bio position as of Q1 2023 after selling out during the quarter.
  • Baupost Group sold 4,808,194 Nuvation Bio shares in Q1 2023, an estimated $9.23M.
  • Baupost Group first reported a position in Nuvation Bio in Q1 2021 and held it in 8 quarters.
  • Baupost Group's Nuvation Bio position peaked at $85.4M in Q3 2021.
  • 129 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2023.

Based on Baupost Group's 13F filing for Q1 2023, filed 12 May 2023.